Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,889 | 69,855 | 26,054 | 43,583 | 44,518 |
| Marketable Securities | 80,327 | 30,955 | 82,492 | 55,278 | 22,183 |
| Receivables | 49,007 | 46,765 | 28,936 | 19,412 | 14,024 |
| Inventories | 67,476 | 55,947 | 41,046 | 28,502 | 24,329 |
| Income taxes - deferred | 10,842 | 3,966 | N/A | N/A | N/A |
| TOTAL | $265,952 | $216,238 | $191,621 | $152,273 | $107,952 |
| Non-Current Assets | |||||
| PPE Net | 27,451 | 25,461 | 20,072 | 16,556 | 11,662 |
| Investments And Advances | 16,168 | 95,172 | 98,197 | 33,450 | 64,335 |
| Intangibles | 132,933 | 99,054 | 79,118 | 45,164 | 31,525 |
| Other Non-Current Assets | 5,928 | 20,788 | 23,518 | 27,225 | 12,114 |
| TOTAL | $182,480 | $240,475 | $220,905 | $122,395 | $119,636 |
| Total Assets | $448,432 | $456,713 | $412,526 | $274,668 | $227,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,576 |
| Accounts payable and accrued liabilities | 8,978 | 10,160 | 7,947 | 3,764 | 2,924 |
| Accrued Expenses | 21,506 | 13,052 | 11,897 | 10,249 | 5,550 |
| Other current liabilities | N/A | N/A | N/A | 7,908 | 4,843 |
| TOTAL | $31,287 | $24,234 | $20,618 | $21,921 | $19,146 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 118,900 | 119,257 | N/A | N/A |
| Deferred Revenues | 88 | N/A | N/A | N/A | 772 |
| Other Non-Current Liabilities | 124,807 | 5,756 | 3,703 | 1,887 | 437 |
| TOTAL | $127,327 | $124,656 | $123,378 | $5,150 | $4,386 |
| Total Liabilities | $158,614 | $148,890 | $143,996 | $27,071 | $23,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,870 | 58,623 | 56,926 | 54,652 | 52,536 |
| Common Shares | 298 | 292 | 286 | 272 | 261 |
| Retained earnings | 36,929 | -265 | -17,462 | -44,323 | -79,600 |
| Other shareholders' equity | -4,588 | 6,194 | 3,990 | 1,641 | -626 |
| TOTAL | $289,818 | $307,823 | $268,530 | $247,597 | $204,056 |
| Total Liabilities And Equity | $448,432 | $456,713 | $412,526 | $274,668 | $227,588 |